← Scroll for more →
Financial Statements — SCTX
Balance Sheet
(in millions USD)| Metric | Q2 2026 |
|---|---|
| Cash & Equivalents | 35.59 |
| Short-term Investments | 7.42 |
| Total Current Assets | 45.11 |
| Property, Plant & Equipment | 5.76 |
| Total Non-current Assets* | 12.82 |
| Total Assets | 57.93 |
| Accounts Payable | 7.18 |
| Total Current Liabilities | 78.70 |
| Total Non-current Liabilities* | 23.72 |
| Total Liabilities | 102.42 |
| Retained Earnings | (181.53) |
| Total Stockholder Equity | (164.85) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 |
|---|---|
| Total Revenue | 1.92 |
| Research & Development | 8.82 |
| Selling, General & Admin | 2.49 |
| Total Operating Expenses | 11.31 |
| Operating Income | (9.39) |
| Interest Expense | 0.88 |
| Pretax Income | (6.26) |
| Tax Provision | 0.21 |
| Net Income | (6.48) |
| Basic EPS | (2.62) |
| Diluted EPS | (2.62) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | (12.89) |
| Capital Expenditures | 0.03 |
| Free Cash Flow* | (12.92) |
| Investing Cash Flow | 37.47 |
| Financing Cash Flow | (1.79) |
← Scroll for more columns →
* Derived from reported values